Amicus Therapeutics (FOLD) Tops Q3 EPS by 1c

Amicus Therapeutics (NASDAQ: FOLD) reported Q3 EPS of ($0.07), $0.01 better than the analyst estimate of ($0.08). Revenue for the quarter came in at $103.5 million versus the consensus estimate of $102.3 million.

For earnings history and earnings-related data on Amicus Therapeutics (FOLD) click here.

You May Also Be Interested In

• ​Trump said he was unaware of his earnings from crypto
• RBC Capital Downgrades Bucher Industries AG (BUCN:SW) (BCHHF) to Sector Perform
• Goldman's Garrett sees investors dialing back tech exposure into H2